Xencor Inc
XNCR- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001326732
No open-market purchases or sales by Xencor Inc insiders were filed in the last 90 days; 208 institutions reported holding it in 13F filings for Q2 2026, worth $1.36B in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +8 vs. previous quarter
- 208
- 13F valueReported value at the end of Q2 2026
- $1.36B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding XNCR, Q2 2026
No superinvestor reported holding XNCR at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Xencor Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 22, 2026 (view filing) | Jun 18 | 4 days | Feigal EllenDirector | SSale | −6.84K | $13.06 | −$89.4K | −35.7%12.3K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Gustafson Kurt ADirector | SSale | −5.47K | $12.31 | −$67.4K | −27.1%14.7K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Montgomery Alan BruceDirector | SSale | −5.06K | $12.31 | −$62.3K | −24.6%15.5K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Ranieri Richard JDirector | SSale | −5.47K | $12.31 | −$67.4K | −28.5%13.7K after | 10b5-1 |
| Jun 17, 2026 (view filing) | Jun 15 | 2 days | Gorman Kevin CharlesDirector | SSale | −7.53K | $12.31 | −$92.7K | −39.8%11.4K after | 10b5-1 |
| Apr 13, 2026 (view filing) | Apr 10 | 3 days | Cornelissen Bart JanSR. VICE PRESIDENT & CFO | SSale | −3.50K | $12.29 | −$43.0K | −4.4%75.9K after | |
| Mar 9, 2026 (view filing) | Mar 5 | 4 days | Cornelissen Bart JanSR. VICE PRESIDENT & CFO | SSale | −2.52K | $11.25 | −$28.3K | −3.1%79.4K after | |
| Mar 9, 2026 (view filing) | Mar 5-6 | 4 days | Eckert CeliaSVP, GENERAL COUNSEL | SSale | −5.01K | $11.17 | −$56.0K | −6.1%76.9K after | 2 lots |
| Mar 9, 2026 (view filing) | Mar 5-6 | 4 days | Desjarlais John RSR. VICE PRESIDENT & CSO | SSale | −6.62K | $11.16 | −$73.9K | −2.4%263.8K after | 2 lots |
| Mar 9, 2026 (view filing) | Mar 5-6 | 4 days | Dahiyat Bassil IPRESIDENT & CEO | SSale | −21.5K | $11.18 | −$240.1K | −3.8%546.3K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in Xencor Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 13,651,261 | $219.8M | 0.00% | +615,343+4.7% | Added |
| Primecap Management Co | 10,181,322 | $163.9M | 0.10% | −156,700−1.5% | Reduced |
| BVF Inc | 7,133,720 | $114.9M | 2.94% | 00.0% | Unchanged |
| RTW Investments, LP | 6,777,461 | $109.1M | 0.93% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 5,274,274 | $84.9M | 0.74% | +377,037+7.7% | Added |
| State Street Corp | 4,954,016 | $79.8M | 0.00% | +601,980+13.8% | Added |
| Vanguard Capital Management LLC | 3,278,802 | $52.8M | 0.00% | +177,155+5.7% | Added |
| TCG Crossover Management, LLC | 2,452,138 | $39.5M | 0.95% | 00.0% | Unchanged |
| Price T Rowe Associates Inc | 2,356,409 | $37.9M | 0.00% | +795,989+51.0% | Added |
| Vanguard Portfolio Management LLC | 2,215,690 | $35.7M | 0.00% | −1,284,652−36.7% | Reduced |